Fundraising Fox

Ruchita Sinha

Investor

General Partner at AV8 Ventures · Board director at Brave Care

San Francisco Bay Area

Writes $500K – $5M checks · typically $2M

About

Ruchita Sinha combines deep cellular and molecular biology training with an MBA in finance and Sanofi‑Genzyme BioVentures leadership experience to offer technical, pharma-focused guidance on company and clinical program design.

Contact· self-published, not guessed

Invests in

AI & Machine LearningBiotechDigital HealthEnterprise SoftwareFintechHealthtechInsurTech

Board director at Brave CareYC S19

Intro paths

YC

Ruchita went through Y Combinator (Summer 2019) — any YC alum in your network can reach them through the YC community.

In turn, Ruchita can intro founders to Brave Care's investors below.

Co-founders at Brave Care

AMAsa Miller
Asa MillerFounder
MTMaryam Taheri
CFCorey Fish, MD
Corey Fish, MDFounder

Experience

  1. ARTIS VenturesSenior Partnercurrent2025 — present
  2. AV8 VenturesVenture Partnercurrent2019 — presentSan Francisco Bay Area
  3. SanofiSr. Director of Investments2016 — 2019
  4. GE VenturesDirector, GE Ventures2013 — 2016Menlo Park, CA
  5. Pfizer PharmaceuticalsDirector, Strategy, Portfolio Management, and Commercial Operations2010 — 2013Greater New York City Area
  6. L.E.K. ConsultingSr. Consultant2007 — 2010Greater New York City Area
  7. MaxygenResearch Associate2001 — 2005San Francisco Bay Area

Skills & more

Business Strategy23Venture Capital10Mergers1Business Development9Marketing Strategy2Cross-functional Team Leadership24Biotechnology8Management Consulting2LifesciencesCorporate Development1Due Diligence2Valuation
+12 moreFinancial ModelingProduct DevelopmentCompetitive AnalysisStart-upsMarket AnalysisTechnology TransferMergers & AcquisitionsMedical DevicesStrategyStrategic PlanningPharmaceutical IndustryLife Sciences

From Ruchita's professional profile.

Investments

Investor

AetionClick TherapeuticsCommon SensingCurisiumEvidation HealthInozymeOmada HealthScience 37

Per the firm's website.

Colleagues at AV8 Ventures

Network1

Investors connected to Ruchita in public investor directories — a warm-intro map.

Frequently asked questions

Who is Ruchita Sinha?
Ruchita Sinha combines deep cellular and molecular biology training with an MBA in finance and Sanofi‑Genzyme BioVentures leadership experience to offer technical, pharma-focused guidance on company and clinical program design.
Where does Ruchita Sinha work?
Ruchita Sinha is General Partner at AV8 Ventures and Board director at Brave Care.
What does Ruchita Sinha invest in?
Ruchita Sinha invests in AI & Machine Learning, Biotech, Digital Health, Enterprise Software, Fintech, Healthtech, InsurTech.
What check size does Ruchita Sinha write?
Ruchita Sinha typically writes checks of $500K – $5M.
What companies has Ruchita Sinha invested in?
Investments tracked here include Aetion, Click Therapeutics, Common Sensing, Curisium, Evidation Health, Inozyme, Omada Health, Science 37.
Where did Ruchita Sinha go to school?
Ruchita Sinha studied at The University of Chicago Booth School of Business (MBA, Finance and Entreprenuership); University of Wisconsin-Madison (Master of Science - MS, Cell/Cellular and Molecular Biology); Mount Holyoke College (BS, Biochemistry).

Same school

Shared employers